This article reviews a variety of options that are available to aid in caring for patients who refuse blood transfusions, ranging from tranexamic acid to erythropoiesis-stimulating agents. With the use of these treatments, patients who decline blood transfusion can be safely managed in situations ranging from elective surgery to stem cell transplant to pregnancy.
According to the results of a new clinical trial published in The New England Journal of Medicine, a simple treatment that combines four heart medicines in one pill—a “polypill”—was able to cut the risk of heart attack, stroke, and other cardiovascular events by 21% in people at risk of heart disease, and by 31% when […]
The possible answer was presented during the 2020 ASH Annual Meeting, bringing into question whether current recommendations for prophylactic intravenous high-dose methotrexate — the most widely adopted method for CNS relapse prevention — are appropriate for all patients at high risk of a CNS relapse.
In the new study, published December 1, 2020 in the open-access journal eLife, researchers from UC San Francisco showed the drug, ISRIB, produced rapid restoration of youthful cognitive abilities in aged mice, accompanied by a rejuvenation of brain and immune cells that could help explain improvements in brain function.
The CDC’s Advisory Committee on Immunization Practices (ACIP) stated goal for deploying a COVID-19 vaccine is “to decrease death and serious disease as much as possible.” According to José Romero, MD, Chair of the ACIP, the decision to vaccinate health care workers first is based on the actions that will help control the pandemic fastest.
According to an international task force at the virtual PAINWeek meeting, chronic pain patients can be treated with medical cannabis following one of three protocols based on patient characteristics. The recommendations are timely considering the limited clinician knowledge about medical cannabis treatment and the opioid crisis.
You take care of others as your profession, but it is also important to remember to take care of yourself. You never know when you’re going to get a break to have a meal between shifts and appointments, so you need something quick, easy, and healthy. These are five tasty ways to keep your energy […]
In this podcast from the virtual 2020 ESMO World Congress on Gastrointestinal Cancer, Dr. Zev Wainberg discusses emerging data from the phase 1/2 trial of first-line liposomal irinotecan plus 5-fluorouracil/leucovorin plus oxaliplatin for pancreatic ductal adenocarcinoma (PDAC).
According to the results of a single-arm, multicenter phase 2 trial in JAMA Oncology, low-dose erlotinib may be a safe and effective option for frail or elderly patients with EGFR mutation-positive NSCLC.